Deferoxamine is a chelating agent used to treat chronic iron overload conditions, such as thalassemia and hemochromatosis, by facilitating the removal of excess iron from the body. This category provides… Read more



















Deferoxamine is a chelating agent used to treat chronic iron overload conditions, such as thalassemia and hemochromatosis, by facilitating the removal of excess iron from the body. This category provides essential reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. These materials are critical for rigorous quality control and method validation, ensuring that pharmaceutical manufacturing processes meet established regulatory safety and potency guidelines. Laboratories rely on these standards for impurity profiling, helping to identify and quantify degradation products formed during processes like hydrolysis, oxidation, or photolysis. Furthermore, stable isotope labelled compounds serve as indispensable internal standards for mass spectrometry and other analytical techniques, providing the precision needed for accurate drug analysis and long-term stability studies.